{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:34:56Z","timestamp":1777858496257,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fundamental Research Grant Scheme","award":["FRGS\/1\/2019\/SKK15\/USIM\/03\/1"],"award-info":[{"award-number":["FRGS\/1\/2019\/SKK15\/USIM\/03\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-026-05939-7","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T11:05:47Z","timestamp":1774177547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complete NUB1 depletion in ER\n-\nnegative breast cancer progression in paired primary\u2013metastatic cases: a case series"],"prefix":"10.1186","volume":"20","author":[{"given":"Maria","family":"Arshad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira Raudhah","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuad","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azyani","family":"Yahaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geok-Chin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suet Lin","family":"Chia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Salzihan Md","family":"Salleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pezzella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ka-Liong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,22]]},"reference":[{"issue":"23","key":"5939_CR1","doi-asserted-by":"publisher","first-page":"20603","DOI":"10.1074\/jbc.M100920200","volume":"276","author":"K Kito","year":"2001","unstructured":"Kito K, Yeh ET, Kamitani T. NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression. J Biol Chem. 2001;276(23):20603\u20139.","journal-title":"J Biol Chem"},{"issue":"49","key":"5939_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102106","volume":"1","author":"KL Tan","year":"2024","unstructured":"Tan KL, Haider S, Zois CE, Hu J, Turley H, Leek R, Buffa F, Acuto O, Harris AL, Pezzella F. Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients. Transl Oncol. 2024;1(49): 102106.","journal-title":"Transl Oncol"},{"issue":"5","key":"5939_CR3","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/sj.bjc.6605574","volume":"102","author":"T Hosono","year":"2010","unstructured":"Hosono T, Tanaka T, Nakatani T, Kamitani T. NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation. Br J Cancer. 2010;102(5):873\u201382.","journal-title":"Br J Cancer"},{"key":"5939_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.961637","volume":"12","author":"G Chen","year":"2022","unstructured":"Chen G, Yu M, Cao J, Zhao Y. Role of hypoxia in the tumor microenvironment and targeted therapy. Front Oncol. 2022;12: 961637.","journal-title":"Front Oncol"},{"issue":"29","key":"5939_CR5","doi-asserted-by":"publisher","first-page":"20045","DOI":"10.1074\/jbc.M603063200","volume":"281","author":"G Schmidtke","year":"2006","unstructured":"Schmidtke G, Aichem A, Groettrup M. The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10. J Biol Chem. 2006;281(29):20045\u201354.","journal-title":"J Biol Chem"},{"issue":"3","key":"5939_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.molonc.2012.01.003","volume":"6","author":"T Tanaka","year":"2012","unstructured":"Tanaka T, Nakatani T, Kamitani T. Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy. Mol Oncol. 2012;6(3):267\u201375.","journal-title":"Mol Oncol"},{"issue":"8","key":"5939_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.153002","volume":"216","author":"D Zhang","year":"2020","unstructured":"Zhang D, Xu C, Wang B, Lin S, Zhang N, Zhang L, et\u00a0al. Overexpression of negative regulator of ubiquitin-like proteins 1 (NUB1) inhibits proliferation and invasion of gastric cancer cells through upregulation of p27Kip1 and inhibition of epithelial-mesenchymal transition. Pathol Res Pract. 2020;216(8): 153002.","journal-title":"Pathol Res Pract"},{"key":"5939_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.628136","volume":"12","author":"D Jia","year":"2021","unstructured":"Jia D, Lu M, Jung KH, Park JH, Yu L, Onuchic JN, et\u00a0al. Breast cancer case identification based on deep learning and bioinformatics analysis. Front Genet. 2021;12: 628136.","journal-title":"Front Genet"},{"key":"5939_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01068","volume":"9","author":"Q Wu","year":"2019","unstructured":"Wu Q, Ma G, Zhang X, Zhao W, Huang Q, Ma G, et\u00a0al. Prognostic value of Ki-67 in patients with resected triple-negative breast cancer: a meta-analysis. Front Oncol. 2019;9: 1068.","journal-title":"Front Oncol"},{"issue":"5","key":"5939_CR10","first-page":"355","volume":"70","author":"GM Choong","year":"2020","unstructured":"Choong GM, Cullen GD, O\u2019Sullivan CC. Evolving standards of care and new challenges in the management of HER2-positive breast cancer. CA Cancer J Clin. 2020;70(5):355\u201374.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"5939_CR11","first-page":"2929","volume":"5","author":"X Dai","year":"2015","unstructured":"Dai X, Li T, Bai Z, Yang Y, Liu X, Zhan J, et\u00a0al. Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res. 2015;5(10):2929\u201343.","journal-title":"Am J Cancer Res"},{"issue":"6282","key":"5939_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.aaf2784","volume":"352","author":"S Turajlic","year":"2016","unstructured":"Turajlic S, Swanton C. Metastasis as an evolutionary process. Science. 2016;352(6282):169\u201375.","journal-title":"Science"},{"issue":"6","key":"5939_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.0010066","volume":"1","author":"MS Scott","year":"2005","unstructured":"Scott MS, Calafell SJ, Thomas DY, Hallett MT. Refining protein subcellular localization. PLoS Comput Biol. 2005;1(6): e66.","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"5939_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13061307","volume":"13","author":"M Arshad","year":"2025","unstructured":"Arshad M, Abdullah AR, Ismail F, Pezzella F, Yahaya A, Tan GC, et\u00a0al. Mechanism and predictive role of NUB1 protein in oestrogen receptor pathway of FEC-treated breast cancer patients. Biomedicines. 2025;13(6): 1307.","journal-title":"Biomedicines"},{"issue":"9","key":"5939_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092176","volume":"10","author":"M Arshad","year":"2021","unstructured":"Arshad M, Tan KL, Abdullah AR, Yahaya A, Salleh MS, Tan GC, et\u00a0al. NUB1 and FAT10 proteins as potential novel biomarkers in cancer: a translational perspective. Cells. 2021;10(9): 2176.","journal-title":"Cells"},{"issue":"24","key":"5939_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246237","volume":"14","author":"C Tinterri","year":"2022","unstructured":"Tinterri C, D\u2019Aiuto M, Ferrucci M, Ciocca M, Fumagalli L, Latronico A, et\u00a0al. Loco-regional treatment of the primary tumor in de novo metastatic breast cancer patients undergoing front-line chemotherapy. Cancers (Basel). 2022;14(24): 6237.","journal-title":"Cancers (Basel)"},{"key":"5939_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.breast.2023.03.016","volume":"69","author":"D Gentile","year":"2023","unstructured":"Gentile D, Balduzzi S, Corti C, Fumagalli L, Munzone E, Colleoni M. Pathologic response and residual tumor cellularity after neo-adjuvant chemotherapy predict prognosis in breast cancer patients. Breast. 2023;69:323\u20139.","journal-title":"Breast"},{"issue":"29","key":"5939_CR18","doi-asserted-by":"publisher","first-page":"45263","DOI":"10.18632\/oncotarget.9481","volume":"7","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Shi CC, Zhang HP, Li GQ, Li SS. MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcoma. Oncotarget. 2016;7(29):45263\u201374.","journal-title":"Oncotarget"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-05939-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-05939-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-05939-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:14:16Z","timestamp":1777508056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-05939-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,22]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5939"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-05939-7","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,22]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review board of the University of Oxford approved the study protocol (C02.216, \u201cThe pathobiology of neoplasia in human tissues\u201d).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}